New chemo combo aims to slow tough-to-treat prostate cancer
Disease control
Recruiting now
This study tests whether adding a second chemotherapy drug (platinum) to the usual treatment (docetaxel) can slow the growth of advanced prostate cancer that no longer responds to hormone therapy. It is for people whose tumors have certain DNA repair gene changes. About 236 parti…
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC